Skip to main content
Livermore
Livermore
ZHEN

Citius Pharmaceuticals, Inc.

CTXR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001506251

No open-market purchases or sales by Citius Pharmaceuticals, Inc. insiders were filed in the last 90 days; 42 institutions reported holding it in 13F filings for Q2 2026, worth $822.4K in total; no superinvestor holds it.

13F holders, Q4 2024

Institutional positions in Citius Pharmaceuticals, Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
30
−28 vs. Q3 2024
Shares held
639.6K
−304.5K (−32.3%) vs. Q3 2024Converted for a 1-for-25 split
Total value
$2.43M
−$9.38M (−79.4%) vs. Q3 2024
New holders
7
11 more added
Sold out
35
5 more reduced

Compare with Q3 2024: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting CTXR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2024: 30 institutions
Q1 2021: 39 institutionsQ2 2021: 74 institutionsQ3 2021: 71 institutionsQ4 2021: 77 institutionsQ1 2022: 76 institutionsQ2 2022: 60 institutionsQ3 2022: 57 institutionsQ4 2022: 54 institutionsQ1 2023: 56 institutionsQ2 2023: 75 institutionsQ3 2023: 74 institutionsQ4 2023: 74 institutionsQ1 2024: 73 institutionsQ2 2024: 72 institutionsQ3 2024: 58 institutionsQ4 2024: 30 institutionsQ1 2025: 28 institutionsQ2 2025: 31 institutionsQ3 2025: 34 institutionsQ4 2025: 39 institutionsQ1 2026: 38 institutionsQ2 2026: 42 institutions
Value heldQ4 2024: $2.43M
Q1 2021: $19.3MQ2 2021: $87.6MQ3 2021: $51.1MQ4 2021: $37.6MQ1 2022: $43.2MQ2 2022: $14.0MQ3 2022: $16.6MQ4 2022: $11.2MQ1 2023: $16.9MQ2 2023: $30.4MQ3 2023: $17.1MQ4 2023: $20.3MQ1 2024: $24.2MQ2 2024: $17.9MQ3 2024: $11.8MQ4 2024: $2.43MQ1 2025: $947.2KQ2 2025: $1.48MQ3 2025: $773.2KQ4 2025: $1.34MQ1 2026: $896.9KQ2 2026: $822.4K
Institutions holding CTXR and their total value by quarter
QuarterHoldersValue
Q2 202642$822.4K
Q1 202638$896.9K
Q4 202539$1.34M
Q3 202534$773.2K
Q2 202531$1.48M
Q1 202528$947.2K
Q4 202430$2.43M
Q3 202458$11.8M
Q2 202472$17.9M
Q1 202473$24.2M
Q4 202374$20.3M
Q3 202374$17.1M
Q2 202375$30.4M
Q1 202356$16.9M
Q4 202254$11.2M
Q3 202257$16.6M
Q2 202260$14.0M
Q1 202276$43.2M
Q4 202177$37.6M
Q3 202171$51.1M
Q2 202174$87.6M
Q1 202139$19.3M

Institutions, Q4 2024

Shares, value and share of portfolio for each institution holding Citius Pharmaceuticals, Inc.; share changes are against Q3 2024.

Institutions holding CTXR in Q4 2024
InstitutionSharesValue% of portfolioChange in sharesAction
Vanguard Group Inc257,631$1.03M0.00%00.0%UnchangedConverted for a 1-for-25 split
Geode Capital Management, LLC76,506$306.1K0.00%+1,348+1.8%AddedConverted for a 1-for-25 split
BlackRock, Inc.72,227$288.9K0.00%00.0%UnchangedConverted for a 1-for-25 split
Squarepoint Ops LLC49,668$198.7K0.00%+23,293+88.3%AddedConverted for a 1-for-25 split
Millennium Management LLC32,320$129.3K0.00%−14,020−30.3%ReducedConverted for a 1-for-25 split
UBS Group AG27,567$110.3K0.00%+27,543+113,813.2%AddedConverted for a 1-for-25 split
State Street Corp23,271$93.1K0.00%00.0%UnchangedConverted for a 1-for-25 split
Fisher Asset Management, LLC12,800$51.2K0.00%+12,800New
Northern Trust Corp12,773$51.1K0.00%00.0%UnchangedConverted for a 1-for-25 split
Arkadios Wealth Advisors10,000$40.0K0.00%+2,000+25.0%AddedConverted for a 1-for-25 split
Tower Research Capital LLC (TRC)8,212$32.8K0.00%+8,050+4,976.7%AddedConverted for a 1-for-25 split
IFP Advisors, Inc40,416$32.8K0.00%+39,083+2,931.2%AddedConverted for a 1-for-25 split
Group One Trading, L.P.4,817$19.3K0.00%+3,991+483.2%AddedConverted for a 1-for-25 split
Royal Bank of Canada4,000$16.0K0.00%+4,000New
SBI Securities Co., Ltd.2,282$9.13K0.00%+2,282New
Advisor Group Holdings, Inc.1,527$6.11K0.00%−35,746−95.9%ReducedConverted for a 1-for-25 split
Simplex Trading, LLC1,720$6.00K0.00%+1,378+403.3%AddedConverted for a 1-for-25 split
Fairscale Capital, LLC366$1.46K0.00%00.0%UnchangedConverted for a 1-for-25 split
Luminist Capital LLC340$1.36K0.00%+340New
Morgan Stanley318$1.27K0.00%+258+430.0%AddedConverted for a 1-for-25 split
Princeton Global Asset Management LLC160$6400.00%00.0%UnchangedConverted for a 1-for-25 split
Murphy & Mullick Capital Management Corp160$6400.00%+160New
JPMorgan Chase & Co124$4960.00%+2+1.9%AddedConverted for a 1-for-25 split
BNP Paribas Arbitrage, SA121$4840.00%+2+1.4%AddedConverted for a 1-for-25 split
Quent Capital, LLC108$4320.00%−2−1.9%ReducedConverted for a 1-for-25 split
Citigroup Inc73$2920.00%−565−88.6%ReducedConverted for a 1-for-25 split
Bank of America Corp55$2200.00%−1,102−95.2%ReducedConverted for a 1-for-25 split
WR Wealth Planners, LLC4$160.00%00.0%UnchangedConverted for a 1-for-25 split
Danske Bank A/S2$80.00%+2New
Citadel Advisors LLC1$40.00%+1New
Armistice Capital, LLC0$00.00%−291,040−100.0%Sold outConverted for a 1-for-25 split
Chelsea Counsel Co0$00.00%−11,252−100.0%Sold outConverted for a 1-for-25 split
HighTower Advisors, LLC0$00.00%−8,601−100.0%Sold outConverted for a 1-for-25 split
Wealth Advisory Solutions, LLC0$00.00%−8,040−100.0%Sold outConverted for a 1-for-25 split
Susquehanna International Group, LLP0$00.00%−6,603−100.0%Sold outConverted for a 1-for-25 split
Inspire Advisors, LLC0$00.00%−6,318−100.0%Sold outConverted for a 1-for-25 split
Point72 Asia (Singapore) Pte. Ltd.0$00.00%−4,021−100.0%Sold outConverted for a 1-for-25 split
Virtu Financial LLC0$00.00%−4,016−100.0%Sold outConverted for a 1-for-25 split
Miller Investment Management, LP0$00.00%−3,986−100.0%Sold outConverted for a 1-for-25 split
Jane Street Group, LLC0$00.00%−3,738−100.0%Sold outConverted for a 1-for-25 split
XTX Topco Ltd0$00.00%−3,730−100.0%Sold outConverted for a 1-for-25 split
Kestra Advisory Services, LLC0$00.00%−3,701−100.0%Sold outConverted for a 1-for-25 split
Blair William & Co0$00.00%−3,648−100.0%Sold outConverted for a 1-for-25 split
Charles Schwab Investment Management Inc0$00.00%−3,043−100.0%Sold outConverted for a 1-for-25 split
Horst & Graben Wealth Management LLC0$00.00%−3,029−100.0%Sold outConverted for a 1-for-25 split
Qube Research & Technologies Ltd0$00.00%−2,884−100.0%Sold outConverted for a 1-for-25 split
Private Advisor Group, LLC0$00.00%−1,600−100.0%Sold outConverted for a 1-for-25 split
Goldman Sachs Group Inc0$00.00%−1,518−100.0%Sold outConverted for a 1-for-25 split
HRT Financial LP0$00.00%−1,487−100.0%Sold outConverted for a 1-for-25 split
TCG Advisory Services, LLC0$00.00%−1,200−100.0%Sold outConverted for a 1-for-25 split
Catalyst Funds Management Pty Ltd0$00.00%−1,088−100.0%Sold outConverted for a 1-for-25 split
Victory Capital Management Inc0$00.00%−855−100.0%Sold outConverted for a 1-for-25 split
Financial Engines Advisors L.L.C.0$00.00%−800−100.0%Sold outConverted for a 1-for-25 split
Keynote Financial Services LLC0$00.00%−700−100.0%Sold outConverted for a 1-for-25 split
Bank of New York Mellon Corp0$00.00%−585−100.0%Sold outConverted for a 1-for-25 split
LPL Financial LLC0$00.00%−459−100.0%Sold outConverted for a 1-for-25 split
Csenge Advisory Group0$00.00%−600−100.0%Sold outConverted for a 1-for-25 split
Ethos Financial Group, LLC0$00.00%−400−100.0%Sold outConverted for a 1-for-25 split
Ronald Blue Trust, Inc.0$00.00%−120−100.0%Sold outConverted for a 1-for-25 split
Sanctuary Advisors, LLC0$00.00%−500−100.0%Sold outConverted for a 1-for-25 split
Cubist Systematic Strategies, LLC0$00.00%−52−100.0%Sold outConverted for a 1-for-25 split
Allworth Financial LP0$00.00%−12−100.0%Sold outConverted for a 1-for-25 split
Aspire Private Capital, LLC0$00.00%−12−100.0%Sold outConverted for a 1-for-25 split
EverSource Wealth Advisors, LLC0$00.00%−1−100.0%Sold outConverted for a 1-for-25 split
Barclays PLC0$00.00%−0−100.0%Sold outConverted for a 1-for-25 split